(2017). Managing glycaemia in older people with type 2 diabetes: A retrospective, primary care-based cohort study, with economic assessment of patient outcomes. Diabetes Obes Metab. http://doi.org/10.1111/dom.12867
. M. Evans
First name
M.
Last name
Evans
(2018). Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink. BMC Nephrol. http://doi.org/10.1186/s12882-018-1007-1
. (2018). Treatment choice, medication adherence and glycemic efficacy in people with type 2 diabetes: a UK clinical practice database study. BMJ Open Diabetes Res Care. http://doi.org/10.1136/bmjdrc-2018-000512
. (2019). Real-World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney Disease or Heart Failure in the United Kingdom. J Am Heart Assoc. http://doi.org/10.1161/jaha.119.012655
. (2019). Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK. ESC Heart Fail. http://doi.org/10.1002/ehf2.12402
. (2020). What Next After Metformin in Type 2 Diabetes? Selecting the Right Drug for the Right Patient. Diabetes Ther. http://doi.org/10.1007/s13300-020-00834-w
.